Description of Vivosim Labs Inc's Business Segments

As of March 31, 2026, the Company operated a single segment. The Company previously had a product-based division called Mosaic, established in the fourth quarter of fiscal 2024, which produced cell-based products for research and development and life science customers. Mosaic's commercial operations ceased in the third quarter of fiscal 2025.

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Composition of Vivosim Labs Inc Revenues by Segments


Royalty		100 %	of total Revenue

Q1 three months ended (Jun 30 2026)
Revenues by Business Segments	Revenues (in millions $)	% (of total Revenues)
Royalty	0.02	100 %
Total	0.02	100 %

Q1 three months ended (Jun 30 2026)
Revenue Growth rates by Segment	Y/Y Revenue %	Q/Q Revenue %
Royalty	-51.35 %	-86.26 %
Total	-51.35 %	-55 %

Q1 three months ended (Jun 30 2026)
Income by Business Segments	Income (in millions $)	% (Profit Margin)
Total	-1.34	-

Q1 three months ended (Jun 30 2026)
Income Growth rates by Segment	Y/Y Income %	Q/Q Income %
Total	-	-

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.